BETA TEST Trademark

Trademark Overview

On Tuesday, January 21, 2025, a trademark application was filed for BETA TEST with the United States Patent and Trademark Office. The USPTO has given the BETA TEST trademark a serial number of 99014100. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 12, 2026. This trademark is owned by KI HEALTH. The BETA TEST trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diabetes using applicant's proprietary testing process.
beta test

General Information

Serial Number99014100
Word MarkBETA TEST
Filing DateTuesday, January 21, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, February 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of The Greek letter β followed by the letters eta, a space and then the word Test.
Goods and ServicesMedical testing for diabetes using applicant's proprietary testing process.
NOT AVAILABLE"Test"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 21, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKI HEALTH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaint Augustine, FL 32095

Trademark Events

Event DateEvent Description
Tuesday, January 21, 2025NEW APPLICATION ENTERED
Tuesday, January 21, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, June 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 25, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 1, 2025ASSIGNED TO EXAMINER
Wednesday, July 2, 2025NON-FINAL ACTION WRITTEN
Wednesday, July 2, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 30, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, October 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 18, 2025FINAL REFUSAL WRITTEN
Tuesday, November 18, 2025FINAL REFUSAL E-MAILED
Tuesday, November 18, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, February 8, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, February 8, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 8, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 12, 2026NON-FINAL ACTION WRITTEN
Thursday, February 12, 2026NON-FINAL ACTION E-MAILED
Thursday, February 12, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

test beta testing proprietary process applicant using diabetes medical